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ABSTRACT 
Introduction: This is a retrospective study that 
aimed to examine the outcomes of patients 
presenting with juvenile nasopharyngeal 
angiofibroma (JNA) at a tertiary centre in 
Malaysia.
Methods: The demographical data, clinical 
presentation, investigations as well as treatment 
of 13 JNA patients were reviewed and collected 
from the medical record office at our centre from 
1995 to 2005. 
Results: All JNA patients were male and the 
average age at diagnosis was 17 (range 14–28) 
years. They presented with recurrent painless 
spontaneous epistaxis, nasal obstruction, nasal 
discharge, a reduced sense of smell, snoring, 
headache and facial swelling. One patient was 
at stage I, eight were at stage II, three at  stage 
III and one patient was at stage IV, based on the 
Fisch classification. Angiography showed that 
nine tumours were supplied by both internal 
maxillary arteries of the external carotid system, 
and only four tumours received blood supply from 
the ipsilateral internal maxillary artery. All 13 
patients underwent primary surgical resection. 
The overall recurrence rate was 38.5 percent for 
the first procedure and 60 percent for the second 
procedure. No major complications occurred 
in this group of patients as a consequence of 
treatment, neither for the primary tumours nor 
for the recurrences.
Conclusion: JNA is a rare vascular benign 
tumour with highly exclusive persistence and 
recurrence, and typically affects adolescent boys. 
The management of JNA presents a challenge to 
ENT surgeons. Preoperative angiography and 
embolisation minimise intraoperative blood 
loss and the current shift in the treatment to 
endoscopic excision in selected lesions reduces 
perioperative morbidity.
Keywords:  angiofibroma, juvenile nasopharyngeal 
angiofibroma, nasopharyngeal tumour
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INTRODUCTION
Juvenile nasopharyngeal angiofibroma (JNA) is a rare, 
histologically benign, highly vascular and locally invasive 
tumour that occurs primarily in male adolescents, with an 
average age of onset at 15 years. It makes up about 0.05% 
of all head and neck neoplasms.(1) This tumour originates 
from the posterolateral wall of the nasal cavity in close 
proximity to the superior aspect of the sphenopalatine 
foramen. It may extend from the nasal cavity to the 
nasopharynx, the paranasal sinuses, the orbit and the 
pterygopalatine fossa, and may even invade the skull base 
or extend intracranially.(2)  Histopathologically, JNA is an 
unencapsulated tumour that is made up of wide vascular 
spaces with single-layered linings, thus the propensity for 
haemorrhage. The blood supply of JNA comes primarily 
from branches of the external carotid system, although 
feeders from the internal carotid artery could contribute to 
its vascularity. The cause of this tumour remains unclear. 
 Most patients present with symptoms of severe, 
recurrent, spontaneous epistaxis with persistent nasal 
obstruction and discharge. As the tumour expands, facial 
deformities, proptosis, blindness, cranial nerve palsies 
and headaches may occur. Several staging systems have 
been proposed, although lately, the Fisch classification 
seems to be the most commonly used.(3) Because of its 
high vascularity, JNA has always presented a treatment 
challenge to surgeons. In the past, surgical excision of the 
tumour was complicated by extensive haemorrhage. With 
the improvements in diagnostic imaging techniques and 
the use of preoperative angiographic embolisation, most 
authorities today recommend surgery as the preferred 
treatment method for JNA. Irradiation has been used as an 
adjuvant to subtotal resection, for both unresectable lesions 
and those with intracranial extension.(2) The purpose of this 
study was to look at the outcomes with the treatment of 13 
JNA patients at a tertiary centre in Malaysia. 
METHODS
This is a retrospective review of 13 patients with JNA treated 
Singapore Med J 2009; 50 (3) : 262
at our centre from 1995 to 2005. The demographical data, 
clinical presentation, investigations as well as treatment 
of these patients were reviewed and collected from the 
medical records. All tumours were classified according to 
the Fisch classification system(3) on the basis of computed 
tomography (CT) (Table I).
RESULTS
JNA was diagnosed in 13 patients at our centre from 1995 
to 2005. All were male and the average age at diagnosis was 
17 years with a range of 14–28 years. All the cases were 
referred from private or government general practitioners. 
Ten out of 13 patients were Malay, two were Chinese 
and one was Indian. All of them presented with recurrent 
painless spontaneous epistaxis. Other symptoms included 
nasal obstruction (76.9%), nasal discharge (76.9%), a 
reduced sense of smell (61.5%), snoring (38.5%), headache 
(23.0%) and facial swelling (7.7%). Nasal endoscopical 
examination of the nasal cavity and nasopharynx revealed a 
nasal mass arising from the nasopharynx in all the patients. 
No biopsies were taken in any of these patients as JNA was 
the primary provisional diagnosis. 
 All patients underwent contrast-enhanced CT for the 
initial assessment, and were classified according to the Fisch 
classification;(3) one patient (7.7%) was at stage I, eight 
(61.5%) were at stage II, three (23.1%) were at stage III and 
one patient (7.7%) was at stage IV (Table II). All patients 
underwent selective angiography. Angiography showed 
nine tumours (69.2%) supplied by both internal maxillary 
arteries of the external carotid system and only four tumours 
(30.8%) received blood supply from the ipsilateral internal 
maxillary artery. Two tumours (18.2%) also received blood 
supply from the internal carotid artery. Internal maxillary 
artery embolisation was carried out in all 13 patients, 
24 hours prior to surgery. For all embolised tumours, an 
immediate control angiogram showed devascularisation 
of the parts of the tumour fed by branches of the external 
carotid arteries. No complications were associated with 
embolisation.
 All 13 patients underwent primary surgical resection 
– eight through a lateral rhinotomy approach, two through 
a combined lateral rhinotomy and transpalatal approach, 
one through a midfacial degloving approach, and two 
through a transnasal endoscopic approach. One patient 
each at stages I and II underwent surgical resection via 
transnasal endoscopy. Seven patients at stage II and one at 
stage III underwent surgical resection via lateral rhinotomy. 
Two patients at stage III underwent surgical resection via 
combined lateral rhinotomy and the transpalatal approach. 
One patient at stage IV underwent the midfacial degloving 
approach to remove the tumour (Table III). 
 The average operation duration was 4 (range 3–7) 
hours. The transnasal endoscopic approach required the 
shortest operative time, averaging about two hours. The 
average surgical blood loss was 1,500 (range 500–3,000) 
ml. Both of the patients who were operated on via the 
transnasal endoscopic approach had the least amount 
of blood loss, which was 500 ml. The average surgical 
blood loss for the nine tumours supplied by both internal 
maxillary arteries of the external carotid system was 1,800 
ml compared to only 1,000 ml of average blood loss of the 
four tumours receiving blood supply from the ipsilateral 
internal maxillary artery. The average operation duration 
for the nine tumours supplied by both internal maxillary 
arteries of the external carotid system was five hours, 
compared with 3.5 hours of average operation duration 
for the four tumours that received blood supply from the 
ipsilateral internal maxillary artery. 
 The patients were transfused with packed cells 
intraoperatively, with a minimum of two units and a 
maximum of seven units, and an average of four units. 
All patients were monitored in the intensive care unit for 
an average of 1.38 days postoperatively. Nasal packing 
remained in place for an average of 5 (range 3–7) days. All 






Table II. Tumour stage and recurrence of angiofibroma.
Fisch’s	stage(3)		 No.	(%)	of		 No.	of	first	 No.	of	second
	 patients	 recurrence	 recurrence
I	 1	(7.7)
II	 8	(61.5)	 2	 1
III	 3	(23.1)	 2	 1
IV	 1	(7.7)	 1	 1
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the nasal packing was removed in the operating room. The 
average length of hospital stay was 10.9 (range 6–18) days. 
The two patients who were operated on via the transnasal 
endoscopic approach had the shortest hospital stay, 
averaging four days, without any complications.
 Two out of eight patients in stage II, two out of three 
patients in stage III and the only patient in stage IV showed 
a recurrence of the tumour averaging at 9 (range 6–27) 
months. In three of these five patients, further recurrences 
occurred, two after six months and one 20 months after the 
second surgery. In the five patients with the first recurrence, 
four of them received radiotherapy treatment and one 
patient underwent transnasal endoscopic removal of the 
recurrent tumour. For the second recurrence, two patients 
post-radiotherapy were treated via a craniofacial approach 
and one repeated with transnasal endoscopic removal of the 
tumour (Table II). The overall recurrence rate was 38.5% 
for the first procedure and 60% for the second procedure. 
It is noteworthy that no major complication occurred in 
this group of patients as a consequence of treatment for 
the primary tumours, nor for the recurrences. The average 
length of follow-up was 26 (range 12–96) months. Two out 
of 13 patients defaulted after 12 months of follow-up, three 
were discharged after five years of being disease-free, and 
the other eight patients are currently still under follow-up. 
DISCUSSION
The demographical data and clinical presentation 
reviewed from this retrospective study are comparable to 
studies done previously.(2,4-7) The typical case presentation 
is usually of an adolescent male with an average age 
of 17 years presenting with spontaneous recurrent 
epistaxis, nasal obstruction and discharge. Other clinical 
presentations depend on the extent of the tumour.(6,7) In 
this study, ten out of 13 (76.9%)  JNA patients were of 
Malay ethnicity, but this data cannot be used to suggest 
that JNA is more common in this ethnic group, as the 
hospital is located in a community where the Malays form 
the majority of the population; and the sample size was 
also small. 
 The diagnosis of JNA is essentially based on a 
careful history, nasal endoscopic examination and is 
supplemented by imaging studies using computed 
tomography or magnetic resonance imaging. Biopsies 
to establish histological diagnosis are contraindicated 
and with advancement in angiography, definite diagnosis 
and embolisation of the tumour-feeding vessels can 
be performed at the same setting. It still remains open 
to debate whether preoperative embolisation helps to 
obscure tumour extensions intraoperatively, increasing the 
likelihood of incomplete tumour removal. However, the 
reduced blood loss during surgery facilitated the removal 
of these tumours dramatically and rendered intraoperative 
or postoperative blood transfusions unnecessary.(4) 
 In our study, preoperative angiography showed nine 
tumours (69.2%) supplied by both internal maxillary 
arteries of the external carotid system and only four tumours 
(30.8%) received blood supply from the ipsilateral internal 
maxillary artery. This was also shown in the study done by 
Pryor et al,(6) where 16 of the JNAs were predominantly 
supplied by the external carotid artery system, with equal 
numbers displaying unilateral or bilateral contributions. We 
also noticed that for the tumours that were supplied by both 
internal maxillary arteries, the average surgical blood loss 
was relatively more, and the average operation duration was 
comparatively longer than the tumours which were only 
supplied by the ipsilateral internal maxillary artery.
 Various methods have been used to treat patients 
with JNA in the past. However, this historical information 
indicates that surgical resection and irradiation therapy are 
the most successful treatments.(2) Therefore, surgery with 
different approaches depends on the stage of the tumour, and 
this remains the primary mode of treatment. Radiotherapy 
is reserved for unresectable lesions.(5) In our centre, all 
13 patients underwent primary surgical resection. The 
approach to tumour resection was dependent on the staging 
of the tumour based on the Fisch classification;(3) treatment 
of stage I  and stage II tumours with minimal paranasal 
sinus involvement was via the transnasal endoscopic route 
unless intraoperative complications develop, especially 
uncontrolled massive bleeding endoscopically. Treatment 
of stage II tumours which invaded the pterygomaxillary 
fossa, and stages III and IV tumours was resected via the 
open approach. Radiotherapy was only offered for recurrent 
tumours. 
 Recurrence is a conspicuous feature of the natural 
history of JNA. Recurrence rates as high as 30%–50% have 
been reported by McCombe et al.(8,9)  Harma reported a 46% 
recurrence in a cohort of 49 patients, 28% of which were 
multiple recurrences.(10) In 1992, Gullane et al reported a 
36% recurrence after surgery in a series of 14 patients.(11) 
In our study, five out of 13 patients (38.5%) had recurrent 
tumours, comparable to the other reports by McCombe et 
al, Harma and Gullane et al.(8-11)
 Advances in endoscopic endonasal surgery coupled 
with the success of preoperative arterial embolisation have 
allowed select cases of JNA to be managed endoscopically. 
The endoscopic approach has permitted the complete 
resection of suitable lesions with very little morbidity. 
Intra- and postoperative complications are reduced with 
endoscopic excision, compared to the standard surgical 
approaches, in selected lesions including Sessions et al’s 
classification stage IIC lesions.(12) In addition, the endoscope 
has been used to improve visualisation in traditional open 
Singapore Med J 2009; 50 (3) : 264
approaches and the reported recurrence rates of properly-
selected endoscopically resected tumours have been low. 
Wormald and Van Hasselt reported no local recurrence in 
seven patients with endoscopically-resected JNA.(13) From 
1995 to 2005, most of our patients were operated on using 
the traditional approach at our centre because of the late 
presentation. With advances in the management of JNA, 
current trends are shifting towards the endoscopic approach 
for the removal of tumours in selected lesions. Further 
studies need to be carried out in the future to assess the 
outcome of the endoscopic approach at our centre.
 In conclusion, JNA is a rare, vascular, benign tumour 
with high exclusivity, persistence and recurrence, and 
typically affects adolescent boys. The management of 
JNA presents a challenge to ENT surgeons. Preoperative 
angiography and embolisation minimise the intraoperative 
blood loss and the current shift in the treatment to endoscopic 
excision in selected lesions reduces perioperative morbidity. 
Larger demographical studies are needed to determine 
whether JNA is linked to a particular race only, especially 
in our multiracial society.
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